Saturday, April 17, 2021 6:59:55 PM
Read my post# 38435 again and put yourself in Relief Therapeutics' shoes and make your own DD. I would like to emphasize again: This is an original Relief-Email.
IMO, it looks like Relief Therapeutics is waiting for pending data from the US trial for RLF-100 (inhaled), for which they provided the funds, and NeuroRx is afraid to hand them over before an EUA is issued.
They may also be prevented from doing so. Who knows that ?
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM